Google
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Disease and COVID-19: An Outline to Decrease Burden and Minimize Morbidity (Adapted for Sub-Saharan Africa)
April 1, 2020– Sickle cell disease (SCD) affects ~100,000 individuals in the United States, 3,000,000 in Africa, and millions globally. Individuals living with SCD suffer from both acute and chronic complications that require close contact with the medical system. These include acute sickle cell pain, fever, and the acute chest syndrome (ACS) which is the term used for a constellation of findings that includes chest pain, cough, fever, hypoxia and new lung infiltrates.
There is a significant concern that the overlap of fever and lung disease from COVID-19 with ACS may result in increased complications and amplification of healthcare utilization among individuals with SCD. Moreover, individuals with SCD, in general, experience high utilization of acute care services including emergency departments and hospitals and often present with fever, signs and symptoms of pneumonia or evolving ACS, as well as acute sickle cell pain requiring parenteral therapy. Thus, there may be specific diagnostic, treatment and logistical challenges in meeting the healthcare needs of this population during the COVID19 pandemic.
+myBinderRelated Content
-
RDLA April 2020 Legislative Webinar – Rare Disease Legislative AdvocatesRare Disease Legislative Advocates Powe...
-
Post Traumatic Stress Disorder – WebinarThe Sickle Cell Mental Health Initiative...
-
MARAC Advisory Statement: COVID-19 VaccinesNews is evolving rapidly about COVID-19 ...
-
You Should Get a COVID-19 Vaccine – Englishhttps://www.youtube.com/watch?v=eeVB7tTU...
-
COVID-19, Sickle Cell Disease, and a Critical NeedWe are facing a global pandemic as cases...
-
Lifestyle Adjustments During COVID-19 – SCDAAhttps://www.sicklecelldisease.org/wp-con...
-
Coronavirus, Racial Disparity in Sickle Cell DiseaseDespite being a rare condition, sickle c...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.